ALICE MOON: Open Payments
NPI 1790724011 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 32 payments from 8 companies in 2025. Trend: 2023 $794 · 2024 $566 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $371 |
| Lundbeck LLC | 8 | $332 |
| ABBVIE INC. | 3 | $80 |
| Boston Scientific Corporation | 3 | $71 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
Products named: REXULTI, ABILIFY MAINTENA, VRAYLAR, WaveWriter Alpha Prime 16, INGREZZA, FANAPT, AUSTEDO XR, UZEDY.
Industry payments across MI — which companies pay providers there.
